Cardiff Lexington Corp. Files S-1/A Amendment
Ticker: CDIX · Form: S-1/A · Filed: May 31, 2024 · CIK: 811222
Sentiment: neutral
Topics: amendment, sec-filing, financial-disclosure
Related Tickers: CDIF
TL;DR
Cardiff Lexington Corp. filed an S-1/A amendment on 5/31/24, updating financials and responding to SEC comments. Check preferred stock details.
AI Summary
Cardiff Lexington Corp. filed an S-1/A amendment on May 31, 2024, responding to SEC comments. The filing details financial information for the period ending March 31, 2024, including various series of preferred stock. The company, formerly known as Cardiff International Inc., is incorporated in Florida and headquartered in Las Vegas, Nevada.
Why It Matters
This amendment provides updated financial disclosures and responses to the SEC, which are crucial for investors to assess the company's current financial health and regulatory compliance.
Risk Assessment
Risk Level: medium — S-1/A filings often indicate a company is seeking to raise capital or has ongoing regulatory scrutiny, which can introduce uncertainty.
Key Numbers
- 333-273324 — SEC File Number (Identifies the specific SEC registration statement)
- 0000811222 — Central Index Key (Unique identifier for the filer)
Key Players & Entities
- Cardiff Lexington Corp. (company) — Filer of the S-1/A amendment
- SEC (company) — Regulatory body to which the filing is submitted
- 20240531 (date) — Date of filing
- March 31, 2024 (date) — End of reporting period for financial data
- Cardiff International Inc. (company) — Former name of Cardiff Lexington Corp.
FAQ
What specific SEC comments is Cardiff Lexington Corp. responding to in this S-1/A filing?
The filing states it is a 'Response to an SEC comment' but does not detail the specific comments within the provided text.
What is the primary purpose of this S-1/A filing?
The filing is an amendment to a registration statement (S-1/A), indicating updates or responses to regulatory requirements, likely related to securities offerings or ongoing disclosures.
What were the company's financial figures for the quarter ending March 31, 2024?
The filing references financial data for the period ending March 31, 2024, including details on various series of preferred stock, but specific dollar amounts for revenue or profit are not provided in this excerpt.
When did Cardiff Lexington Corp. change its name from Cardiff International Inc.?
The date of the name change from Cardiff International Inc. was February 11, 2000.
Where is Cardiff Lexington Corp. headquartered?
The company's business and mailing address is located at 3753 Howard Hughes Parkway, Suite 200, Las Vegas, NV 89169.
Filing Stats: 4,477 words · 18 min read · ~15 pages · Grade level 15.9 · Accepted 2024-05-31 15:04:09
Key Financial Figures
- $5.00 — ck, assuming a public offering price of $5.00 per share (which is the midpoint of the
- $4.00 — e public offering price will be between $4.00 and $6.00 per share. Our common stock
- $6.00 — ffering price will be between $4.00 and $6.00 per share. Our common stock is curren
- $7.00 — common stock on the OTC Pink Market was $7.00. In connection with this offering, we h
- $650,000 — xpense allowance, will be approximately $650,000. We have granted the underwriters an
- $11,853,266 — re business, which generated revenue of $11,853,266 and $10,693,196 for the years ended Dec
- $10,693,196 — ch generated revenue of $11,853,266 and $10,693,196 for the years ended December 31, 2023 a
- $2,661,966 — er 31, 2023 and 2022, respectively, and $2,661,966 and $2,706,399 for the three months end
- $2,706,399 — 2022, respectively, and $2,661,966 and $2,706,399 for the three months ended March 31, 20
- $3,028,394 — cember 31, 2023, we had a net income of $3,028,394, as compared to a net loss of $5,429,52
- $5,429,521 — 3,028,394, as compared to a net loss of $5,429,521 for the year ended December 31, 2022. F
- $283,104 — 31, 2024 and 2023, we had a net loss of $283,104 and $15,991, respectively. 1 Our Cor
- $15,991 — 2023, we had a net loss of $283,104 and $15,991, respectively. 1 Our Corporate Histo
Filing Documents
- cardiff_s1a4.htm (S-1/A) — 2821KB
- cardiff_ex2301.htm (EX-23.1) — 2KB
- image_001.jpg (GRAPHIC) — 10KB
- image_005.jpg (GRAPHIC) — 75KB
- 0001683168-24-003912.txt ( ) — 8693KB
- cdif-20240331.xsd (EX-101.SCH) — 56KB
- cdif-20240331_cal.xml (EX-101.CAL) — 63KB
- cdif-20240331_def.xml (EX-101.DEF) — 186KB
- cdif-20240331_lab.xml (EX-101.LAB) — 335KB
- cdif-20240331_pre.xml (EX-101.PRE) — 287KB
- cardiff_s1a4_htm.xml (XML) — 1170KB
Risk Factors
Risk Factors 12 Cautionary Statement Regarding Forward-Looking Statements 30
Use of Proceeds
Use of Proceeds 32 Dividend Policy 33 Capitalization 34
Dilution
Dilution 37 Market Price of Common Equity and Related Stockholder Matters 39
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 40
Business
Business 52 Management 67
Executive Compensation
Executive Compensation 73 Current Relationships and Related Party Transactions 78 Principal Stockholders 79
Description of Capital Stock
Description of Capital Stock 81 Shares Eligible for Future Sale 93 Material U.S. Federal Income Tax Considerations for Non-U.S. Holders 94
Underwriting
Underwriting 98 Legal Matters 102 Experts 102 Where You Can Find More Information 102
Financial Statements
Financial Statements F-1 i ABOUT THIS PROSPECTUS You should rely only on the information contained in this prospectus or in any free writing prospectuses prepared by us or on our behalf or to which we have referred you. We and the underwriters have not authorized anyone to provide any information or to make any representations other than those contained in this prospectus or in any free writing prospectuses prepared by us or on our behalf or to which we have referred you. We take no responsibility for and can provide no assurance as to the reliability of, any other information that others may give you. This prospectus is an offer to sell only the shares of common stock offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. We are not making an offer to sell these shares of common stock in any jurisdiction where the offer or sale is not permitted or where the person making the offer or sale is not qualified to do so or to any person to whom it is not permitted to make such offer or sale. The information contained in this prospectus is current only as of the date on the front cover of the prospectus. Our business, financial condition, results of operations and prospects may have changed since that date. Persons who come into possession of this prospectus and any applicable free writing prospectus in jurisdictions outside the United States are required to inform themselves about and to observe any restrictions as to this offering and the distribution of this prospectus and any such free writing prospectus applicable to that jurisdiction. See " Underwriting " for additional information on these restrictions. INDUSTRY AND MARKET DATA We are responsible for the disclosure in this prospectus. However, this prospectus includes industry data that we obtained from market research, publicly available information and industry publications. We did not fund and are not otherwise affiliated with any of the sources cited in this pr